Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Cell Reports. Medicine
|
September 19, 2025
Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models
Peyton C High, Zhengdong Liang, Cara Guernsey-Biddle, et al.
Pharmaceutics
|
July 27, 2024
Antitumor Activity of a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma
Jianghua Tu, Yukimatsu Toh, Adela M Aldana, et al.
Journal of Medicinal Chemistry
|
August 18, 2021
Drug Conjugates of Antagonistic R-Spondin 4 Mutant for Simultaneous Targeting of Leucine-Rich Repeat-Containing G Protein-Coupled Receptors 4/5/6 for Cancer Treatment
Jie Cui, Yukimatsu Toh, Soohyun Park, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 26, 2017
Crystal structure of an orthomyxovirus matrix protein reveals mechanisms for self-polymerization and membrane association
Wenting Zhang, Wenjie Zheng, Yukimatsu Toh, et al.
Journal of Medicinal Chemistry
|
April 9, 2026
RSPO2-Based Peptibodies Conjugated with Pyrrolobenzodiazepine Dimer or Camptothecin Analogs Demonstrate Potent Antitumor Activity by Targeting the Three Receptors LGR4/5/6 in Colorectal Cancer and Neuroblastoma
Yukimatsu Toh, Jianghua Tu, Ling Wu, et al.
British Journal of Cancer
|
August 18, 2025
Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer
Yukimatsu Toh, Ling Wu, Jianghua Tu, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
Anti-tumor activity of camptothecin analog conjugate of a RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer
Yukimatsu Toh, Ling Wu, Jianghua Tu, et al.
Human Mutation
|
August 14, 2020
Expansion of germline RPS20 mutation phenotype to include Diamond-Blackfan anemia
Saleh Bhar, Fujun Zhou, Lucas C Reineke, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Cell Reports. Medicine
|
September 19, 2025
Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models
Peyton C High, Zhengdong Liang, Cara Guernsey-Biddle, et al.
Pharmaceutics
|
July 27, 2024
Antitumor Activity of a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma
Jianghua Tu, Yukimatsu Toh, Adela M Aldana, et al.
Journal of Medicinal Chemistry
|
August 18, 2021
Drug Conjugates of Antagonistic R-Spondin 4 Mutant for Simultaneous Targeting of Leucine-Rich Repeat-Containing G Protein-Coupled Receptors 4/5/6 for Cancer Treatment
Jie Cui, Yukimatsu Toh, Soohyun Park, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 26, 2017
Crystal structure of an orthomyxovirus matrix protein reveals mechanisms for self-polymerization and membrane association
Wenting Zhang, Wenjie Zheng, Yukimatsu Toh, et al.
Journal of Medicinal Chemistry
|
April 9, 2026
RSPO2-Based Peptibodies Conjugated with Pyrrolobenzodiazepine Dimer or Camptothecin Analogs Demonstrate Potent Antitumor Activity by Targeting the Three Receptors LGR4/5/6 in Colorectal Cancer and Neuroblastoma
Yukimatsu Toh, Jianghua Tu, Ling Wu, et al.
British Journal of Cancer
|
August 18, 2025
Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer
Yukimatsu Toh, Ling Wu, Jianghua Tu, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
Anti-tumor activity of camptothecin analog conjugate of a RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer
Yukimatsu Toh, Ling Wu, Jianghua Tu, et al.
Human Mutation
|
August 14, 2020
Expansion of germline RPS20 mutation phenotype to include Diamond-Blackfan anemia
Saleh Bhar, Fujun Zhou, Lucas C Reineke, et al.
Page
of 2